Descripción

Molecular pathway diagram details berberine's modulation of AMPK signaling in hepatocytes, illustrating downstream effects on fatty acid oxidation, lipogenesis, and gluconeogenesis relevant to NAFLD pathophysiology.

Figure 5

Diagram

Source Paper

Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Clinical and Pre-Clinical Overview and Systematic Review of the Literature.

International journal of molecular sciences (2024)

PMID: 38673787

DOI: 10.3390/ijms25084201

Cite This Figure

![Figure 5: Molecular pathway diagram details berberine's modulation of AMPK signaling in hepatocytes, illustrating downstream effects on fatty acid oxidation, lipogenesis, and gluconeogenesis relevant to NAFLD pathophysiology.]()

> Source: Florentina Ionita-Radu et al. "Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Cl." *International journal of molecular sciences*, 2024. PMID: [38673787](https://pubmed.ncbi.nlm.nih.gov/38673787/)

<figure>
  <img src="" alt="Molecular pathway diagram details berberine's modulation of AMPK signaling in hepatocytes, illustrating downstream effects on fatty acid oxidation, lipogenesis, and gluconeogenesis relevant to NAFLD pathophysiology." />
  <figcaption>Figure 5. Molecular pathway diagram details berberine's modulation of AMPK signaling in hepatocytes, illustrating downstream effects on fatty acid oxidation, lipogenesis, and gluconeogenesis relevant to NAFLD pathophysiology.<br>  Source: Florentina Ionita-Radu et al. "Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Cl." <em>International journal of molecular sciences</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38673787/">38673787</a></figcaption>
</figure>

Evidencia relacionada

Berberine para Gut Dysbiosis

Calificación D · 2 estudios